Form 4 for MD Pediatrix Medical Group, Inc.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-015674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 2023-03-01 | MD | Swift James D | CEO | A - Grant | $0.00 | +49.8K | 119.7K | +71% | $0 | |
| 2023-03-03 | 2023-03-01 | MD | Swift James D | CEO | F - Tax | $15.74 | -9,909 | 109.8K | -8% | -$156.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 49,758 | $0.00 | 119,740 | D | — | — | (F2) Excludes 17,974 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved. |
| 2 | Common | Common Stock | 2023-03-01 | F | D | 9,909 | $15.74 | 109,831 | D | — | — |